Kyntra Bio, Inc. (KYNB) — Long-term Investment Intensity
Kyntra Bio, Inc. (KYNB) has a Long-term Investment Intensity of 4.0% as of June 2026. Long-term investments of $4.01 Million represent 4.0% of total assets of $101.08 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See KYNB working capital ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Kyntra Bio, Inc. Long-term Investment Intensity (2021–2025)
This chart shows how Kyntra Bio, Inc.'s Long-term Investment Intensity has evolved across 4 annual periods from 2021 to 2025. As of June 2026, the intensity stands at 4.0%, reflecting long-term investments of $4.01 Million against total assets of $101.08 Million USD. See KYNB defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Long-term Investment Intensity for Kyntra Bio, Inc. (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for Kyntra Bio, Inc. from 2021 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see KYNB asset base.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 16.9% | $20.16 Million | $119.59 Million | ▲ +15.6 pp |
| 2023 | 1.2% | $5.29 Million | $423.53 Million | ▼ -0.3 pp |
| 2022 | 1.5% | $9.41 Million | $610.09 Million | ▼ -20.6 pp |
| 2021 | 22.2% | $171.62 Million | $773.82 Million | — |